The Journal of Practical Medicine >

2023 , Vol. 39 >Issue 22: 2969 - 2973

DOI: https://doi.org/10.3969/j.issn.1006-5725.2023.22.019

Clinical Research

Clinical application value of DR⁃dacryocystography in lacrimal duct obstructive diseases

  • Shihuai NIE ,
  • Lixu GUO ,
  • Yong LIU ,
  • Rongxin. CHEN
Expand
  • *.State Key Laboratory of Ophthalmology，Zhongshan Ophthalmic Center，Sun Yat?sen University，Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science，Guangdong Provincial Clinical Research Center for Ocular Diseases，Guangzhou 510060

Received date: 2023-08-10

  Online published: 2023-12-11

Fold

Abstract

Objective This study aimed to explore the clinical value of DR?dacryocystography （DR?DCG） in lacrimal duct obstructive disease， and to further explore the guiding significance of DR?DCG in preoperative evaluation. Methods The DR?DCG of 913 patients （1129 eyes） who came to Zhongshan Ophthalmic Center from January 2019 to December 2019 were collected and analyzed retrospectively. Results （1）Among the 913 cases （1129 eyes） with dacryocystography， a total of 971 eyes were clearly visualized， accounting for 86%； （2） Situation of lacrimal sac visualization： enlarged lacrimal sac in 55 eyes， normal in 438 eyes， and shrink in 478 eyes； （3） The classification of lacrimal obstruction： anterior lacrimal sac obstruction in 80 eyes， high nasolacrimal duct obstruction in 874 eyes， and low nasolacrimal duct obstruction in 97 eyes； （4） Patients with lacrimal drainage system obstruction are 826 patients， accounting for 90.5%， and there were 61 patients with lacrimal duct stenosis， accounting for 6.7%； （5）Patients who chose dacryocystorhinostomy to treat accounted for 62.3%. 902 patients were cured， accounting for 98.9%. Conclusion DR?DCG can clarify the size of the lacrimal sac， the specific site of lacrimal obstruction and its degree of dilatation， with the advantages of simplicity and intuition， and has clinical guidance value for the diagnosis and treatment of lacrimal obstructive diseases.

Key words： DR?dacryocystography; iacrimal duct obstructive disease; treatment methods; clinical application value

Cite this article

Shihuai NIE , Lixu GUO , Yong LIU , Rongxin. CHEN . Clinical application value of DR⁃dacryocystography in lacrimal duct obstructive diseases[J]. The Journal of Practical Medicine, 2023 , 39(22) : 2969 -2973 . DOI: 10.3969/j.issn.1006-5725.2023.22.019

References

1 于欣悦，陈荣新，梁轩伟. 原发性获得性鼻泪管阻塞发病机制的研究进展［J］. 眼科学报，2021，36（11）：921?927.
2 GUL A， ASLAN K， KARLI R， et al. A possible cause of nasolacrimal duct obstruction： narrow angle between inferior turbinate and upper part of the medial wall of the maxillary sinus［J］. Curr Eye Res， 2016， 41（6）：729?733.
3 WANG W， GONG L， WANG Y. Anatomic characteristics of primary acquired nasolacrimal duct obstruction： a comparative computed tomography study［J］. Quant Imaging Med Surg， 2022， 12（11）：5068?5079.
4 KANG T S， CHO J， KIM J， et al. Modified ocular surface disease index as a screening criteria for dry eye syndrome presenting after successful dacryocystorhinostomy［J］. PLoS One， 2021， 16（2）：e0247168.
5 MEHTA S， YING G S， HUSSAIN A， et al. Is gastroesophageal reflux disease associated with primary acquired nasolacrimal duct obstruction？［J］. Orbit， 2018， 37（2）：135?139.
6 BULBUL E， YAZICI A， YANIK B， et al. Morphometric evaluation of bony nasolacrimal canal in a Caucasian population with primary acquired nasolacrimal duct obstruction： a multidetector computed tomography study［J］. Korean J Radiol， 2016， 17（2）： 271.
7 SAMAREI R， SAMAREI V， AIDENLOO N S， et al. Sinonasal Anatomical Variations and Primary Acquired Nasolacrimal Duct Obstruction： A Single Centre， Case?Control Investigation［J］. Eurasian J Med， 2020， 52（1）：21?24.
8 ALI M J， PAULSEN F. Prolactin and Prolactin?inducible protein （PIP） in the pathogenesis of primary acquired nasolacrimal duct obstruction （PANDO）［J］. Med Hypotheses， 2019， 125： 137?138.
9 ALI M J， SCHICHT M， PAULSEN F. Qualitative hormonal profiling of the lacrimal drainage system： potential insights into the etiopathogenesis of primary acquired nasolacrimal duct obstruction［J］. Ophthalmic Plast Reconstr Surg， 2017， 33（5）： 381?388.
10 DIKICI O， ULUTA? H G. Relationship between primary acquired nasolacrimal duct obstruction， paranasal abnormalities and nasal septal deviation［J］. J Craniofacial Surg， 2020， 31（3）： 782?786.
11 SAMAREI R， SAMAREI V， AIDENLOO N S， et al. Sinonasal anatomical variations and primary acquired nasolacrimal duct obstruction： a single centre， case?control investigation［J］. Eurasian J Med， 2020， 52（1）： 21?24.
12 ZHOU X， ZHANG X， ZHOU D， et al. A Narrative Review of Ocular Surface Disease Related to Anti?Glaucomatous Medications［J］. Ophthalmol Ther， 2022， 11（5）：1681?1704.
13 薛利利，张苗，张琳. 先天性鼻泪管阻塞的临床治疗［J］. 眼科学报， 2022， 37（10）：795?798.
14 黄伟锋，陈荣新，赵静，等. 黏膜瓣泪小点成形术治疗慢性泪小管炎的疗效［J］. 眼科学报，2021，36（11）：881?887.
15 KAMAO T， ZHENG X， SHIRAISHI A. Outcomes of bicanalicular nasal stent inserted by sheath?guided dacryoendoscope in patients with lacrimal passage obstruction： a retrospective observational study［J］. BMC Ophthalmol， 2021， 21（1）：103.
16 谭思敏， 梁德茂. Nd： YAG激光泪道成形术联合泪道支架置入治疗泪道阻塞的疗效及影响因素［J］. 国际眼科杂志， 2020， 20（11）： 1979?1982.
17 GOEL R， GOLHAIT P， KHANAM S， et al. Comparative evaluation of dacryocystorhinostomy with retrograde intubation and conjunctivo?dacryocystorhinostomy［J］. Can J Ophthalmol， 2023， 58（1）： 39?46.
18 张福宏，卢蓉，史剑波. 内镜鼻眼相关外科现状与展望［J］. 眼科学报，2022，37（11）：835?842，909.
19 ALAM M S， KUNDU D. Is dacryocystectomy effective in reducing epiphora？［J］. Indian J Ophthalmol， 2022， 70（12）：4416?4418.
20 汤喜成， 魏厚仁. 超声诊断在泪道疾病中的应用［J］. 实用眼科杂志， 1986，4（7）： 419?421.
21 ALI M J， SINGH S， NAIK M N， et al. Interactive navigation?guided ophthalmic plastic surgery： the utility of 3D CT?DCG?guided dacryolocalization in secondary acquired lacrimal duct obstructions［J］. Clin Ophthalmol， 2016， 11： 127?133.
22 HIGASHI H， TAMADA T， MIZUKAWA K， et al. MR dacryocystography： comparison with dacryoendoscopy in positional diagnosis of nasolacrimal duct obstruction［J］. Radiol med， 2016， 121（7）： 580?587.
23 SINGH S， ALI M J， PAULSEN F. Dacryocystography： from theory to current practice［J］. Ann Anat， 2019， 224： 33?40.
24 武俊男，孙悦奇，王康华，等. 经鼻内镜鼻泪管?泪囊切除术的应用解剖［J］. 眼科学报，2022，37（11）：856?863.
25 BAE S H， PARK J， LEE J K. Comparison of digital subtraction dacryocystography and dacryoendoscopy in patients with Epiphora［J］. Eye， 2021， 35（3）： 877?882.
Options
Outlines

/

〈 〉